| Lara Deveraux, LCSW | |
|
934 S Main St, Layton, UT 84041-7135 | |
| (801) 773-7060 | |
| Not Available |
| Full Name | Lara Deveraux |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 37 Years |
| Location | 934 S Main St, Layton, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467740001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6140478-3501 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Davis Behavioral Health Inc | 7416861919 | 44 |
News Archive
H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.
Ampio Pharmaceuticals, Inc. announced today that it's Phase III clinical study of Ampion™ for the treatment for osteoarthritis of the knee will include a dose-escalation run-in study as recommended by the FDA.
All proteins self-assemble in a fraction of the blink of an eye, but it can take a long time to mimic the process. And there has been no guarantee of success, even with the most powerful computers - until now.
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS that allow labs to go live faster and at a lower total cost, today announced the availability of its new purpose-built COVID-19 LIMS solution.
Human lung-cancer tumors grown in mice have been shown to regress or disappear when treated with a synthetic compound that mimics the action of a naturally occurring "death-promoting" protein found in cells, researchers at UT Southwestern Medical Center report.
› Verified 1 days ago
| Entity Name | Davis Behavioral Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770641672 PECOS PAC ID: 7416861919 Enrollment ID: O20031118000909 |
News Archive
H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.
Ampio Pharmaceuticals, Inc. announced today that it's Phase III clinical study of Ampion™ for the treatment for osteoarthritis of the knee will include a dose-escalation run-in study as recommended by the FDA.
All proteins self-assemble in a fraction of the blink of an eye, but it can take a long time to mimic the process. And there has been no guarantee of success, even with the most powerful computers - until now.
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS that allow labs to go live faster and at a lower total cost, today announced the availability of its new purpose-built COVID-19 LIMS solution.
Human lung-cancer tumors grown in mice have been shown to regress or disappear when treated with a synthetic compound that mimics the action of a naturally occurring "death-promoting" protein found in cells, researchers at UT Southwestern Medical Center report.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lara Deveraux, LCSW 934 S Main St, Layton, UT 84041-7135 Ph: (801) 773-7060 | Lara Deveraux, LCSW 934 S Main St, Layton, UT 84041-7135 Ph: (801) 773-7060 |
News Archive
H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.
Ampio Pharmaceuticals, Inc. announced today that it's Phase III clinical study of Ampion™ for the treatment for osteoarthritis of the knee will include a dose-escalation run-in study as recommended by the FDA.
All proteins self-assemble in a fraction of the blink of an eye, but it can take a long time to mimic the process. And there has been no guarantee of success, even with the most powerful computers - until now.
LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS that allow labs to go live faster and at a lower total cost, today announced the availability of its new purpose-built COVID-19 LIMS solution.
Human lung-cancer tumors grown in mice have been shown to regress or disappear when treated with a synthetic compound that mimics the action of a naturally occurring "death-promoting" protein found in cells, researchers at UT Southwestern Medical Center report.
› Verified 1 days ago
Kelley Diane Irmen, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 | |
Michele Tanner, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 | |
Jennifer Lynn Forbes, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 | |
John David Larsen, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 | |
Curtis M. Tesch, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 | |
Alison Coburn, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1660 W Antelope Dr Ste 320, Layton, UT 84041 Phone: 801-773-4840 | |
Brady D Olsen, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 934 S Main St, Layton, UT 84041 Phone: 801-773-7060 |